METHYL (R)-(+)-3-HYDROXY-5-OXO-1-CYCLOPENTENE-1-HEPTANOATE

We are METHYL (R)-(+)-3-HYDROXY-5-OXO-1-CYCLOPENTENE-1-HEPTANOATE CAS:41138-61-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:METHYL (R)-(+)-3-HYDROXY-5-OXO-1-CYCLOPENTENE-1-HEPTANOATE
CAS.NO:41138-61-8
Synonyms:METHYL (R)-(+)-3-HYDROXY-5-OXO-1-CYCLOPENTENE-1-HEPTANOATE
(R)-4-hydroxy-2-(6-carbomethoxyhexyl)-cyclopent-2-enone
(R)-4-hydroxy-2-(6-methoxycarbonylhexyl)-cyclopenta-2-enone
(3R)3-hydroxy-5-oxo-l-cyclopenteneheptanoic acid,methyl ester
methyl (R)-(+)-3-hydroxy-5-oxo-1-cyclo-pentene-1
 
Physical and Chemical Properties:
Density 1.1±0.1 g/cm3
Boiling Point 378.4±42.0 °C at 760 mmHg
Melting Point 59-63ºC
Molecular Formula C13H20O4
Molecular Weight 240.296
Flash Point 138.9±21.4 °C
 
Specification:
Appearance:Off-white to yellow to brown solid
Assay(HPLC):≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Prostaglandin E1(CAS:745-65-3).

METHYL (R)-(+)-3-HYDROXY-5-OXO-1-CYCLOPENTENE-1-HEPTANOATE


Related News: With the structural upgrade of the pharmaceutical industry in developed countries, the transfer of related industrial chains has taken place globally, and it has also had a profound impact on Chinese pharmaceutical companies. nearmetil (E) -2- (2-hidroxifenil) -3-metoxiprop-2-enoato CAS:125808-20-0 The iLet is designed to function as three medical devices in one. It can be configured as an insulin-only bionic pancreas, a glucagon-only bionic pancreas, or a bihormonal bionic pancreas using insulin and glucagon.629-11-8 “Our collaboration with Mankind demonstrates our commitment towards providing novel, innovative treatment options for efficient diabetes management,” Glenmark Pharmaceuticals President, India Formulations, Middle East and Africa Sujesh Vasudevan said.Trimethoxy(1H,1H,2H,2H-perfluorohexyl)silane CAS:85877-79-8 “Our collaboration with Mankind demonstrates our commitment towards providing novel, innovative treatment options for efficient diabetes management,” Glenmark Pharmaceuticals President, India Formulations, Middle East and Africa Sujesh Vasudevan said.Fate Therapeutics’ iPSC product platform is supported by an intellectual property portfolio of over 250 issued patents and 150 pending patent applications.

Related Products
Product Name
(aR,bS)-rel-α-Hydroxy-β-[[(phenylmethoxy)carbonyl]amino]benzenebutanoic acid View Details
Pyridoxine dipalmitate View Details
2-(TRIFLUOROMETHOXY)BENZOYL CHLORIDE View Details
2,4,6-Trifluorobenzonitrile manufacturer 4-Glycidyloxycarbazole manufacturer butyl(triethoxy)silane manufacturer 3,4-Difluorophenyl isothiocyanate manufacturer 7,8-Dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one manufacturer